News

  1. 1
    Dec. 28, 2015 -“FAID 2016” announces 4 new keynote speakers and 15 presenters for February 9-10, 2016, symposium
    Keynote Speakers
    Stéphane Bancel, CEO of Moderna Therapeutics
    Christopher Larkin, CTO, GE Healthcare
    Jonathan Stamler, Director, Harrington Discovery Institute
    Robert G. Urban, Head of J&J Innovation Center, J&J

    Presenters
    Yves Agid, Founder and Scientific Advisor, ICM
    Christian Bréchot, President, Institut Pasteur
    Dan Chung, Medical Affair Opthalmic Lead, Spark Therapeutics
    Pascal Deschaseaux, VP Ai Carnot, General Manager, CALYM
    Malvina B. Eydelman, Director, Division of Opthalmic and Ear, Nose and Throat Devices, FDA
    Arnaud Fontanet, Centre for Global Health, Institut Pasteur
    Johannes Fruehauf, Co-founder, President, LabCentral
    Newton Howard, Chairman, Brain Sciences Foundation
    Christophe Le Tourneau, Head of Early Trials, Institut Curie
    Fanny Mochel, Head, Neurometabolic Research Group, ICM
    Sergio Roman-Roman, Head of Translational Research, Institut Curie
    Emanuela Romano, Head of Immunotherapy Unit, Institut Curie
    Jose-Alain Sahel, Director, Institut de la Vision
    Gilles Salles, Chairman, CALYM
    Pierre Tervé, VP Technic & Scientific Advisor, Keosys
     
     
  2. 2
    Dec. 14, 2015 – Save February 9-10, 2016 to attend the French-American Innovations Days

    BOSTON and PARIS, Dec. 14, 2015 — Organizers announced today that “French-American Innovation Days (FAID) 2016” will be held on Tuesday and Wednesday, February 9 and 10, 2016, at the MIT Media Lab, 75 Amherst Street, Cambridge, Mass. The FAID symposium’s organizers are: The Office for Science and Technology of the Embassy of France in the United-States in Boston; and, GLOBAL CARE Initiative (“GCI”).
     
    The two-day event is focusing on the latest developments in Precision Medicine. It will bring together leading experts in the field, to explore how these developments impact clinical research. The Symposium is also expected to facilitate research and development partnerships among researchers, emerging and established companies, business development executives and investors in the United States and France.
     
    “The FAID symposium will be the ideal venue at which life science investors, researchers and business development executives can learn and network and identify potential collaborators,” said Valéry Freland, Consul General of France in Boston.
     
    “The FAID symposium will be of great interest to those in the life sciences in the U.S. and France who want to see science and technology transferred into clinical reality for the advancement of human health,” added Pascal Deschaseaux, MD, MBA, General Manager, CALYM, a GLOBAL CARE Initiative member.
     
    Sponsorships opportunities are available, please contact GLOBAL CARE Initiative at contact@globalcare-initiative.com

    http://www.businesswire.com/news/home/20151214005963/en/%E2%80%9CFrench-American-Innovation-Days-FAID-2016%E2%80%9D-held-Feb

  3. 3
    Jan. 11, 2016 – “FAID 2016” Announces Big Data in Clinical Trials Presentations and Case Studies as Part of Its February 9-10, 2016, Symposium

    In order of their appearance at the podium, FAID 2016 presenters on the topic of Big Data in Clinical Trials on February 9th will include: Gilles Salles, MD, PhD, Chairman, CALYM; Michel Meignan, MD, PhD, Professor of Nuclear Medicine, Henri Mondor University Hospital; Fabrice Jardin, MD, PhD, Director INSERM U918 Research Team, Centre Henri Becquerel; Pierre Tervé, VP Technic & Scientific Advisor, Keosys; Christopher Larkin, Chief Technology Officer, GE Healthcare; Christophe Le Tourneau, MD, PhD, Head of Early Trials, Institut Curie; Emanuela Romano, MD, PhD, Head of Immunotherapy Unit, Institut Curie; and, Arnaud Fontanet, MD, PhD, Director, Centre for Global Health, Institut Pasteur

    http://www.businesswire.com/news/home/20160111006406/en/%E2%80%9CFAID-2016%E2%80%9D-Announces-Big-Data-Clinical-Trials

  4. 4
    Jan. 19, 2016 – “FAID 2016” symposium will include presentations, a panel and case studies in the session named “From Integrated Business Models & New Funding Strategies for Early-Stage R&D” as part of its February 9-10, 2016, program

    In order of their appearance at the podium, FAID 2016, presenters in this dedicated session on February 10 will include: Christian Bréchot, MD, PhD, President, Institut Pasteur; Robert G. Urban, PhD, Head of Johnson & Johnson Innovation Center, Boston; Jonathan Stamler, MD, Director, Harrington Discovery Institute; Johannes Fruehauf, MD, PhD, Founder & President, LabCentral; Gilles Salles, MD, PhD, Chairman, CALYM Carnot Institute; Kenichi Takeshita, MD, Vice-President, Clinical R&D, Celgene Corporation; Sergio Roman-Roman, PharmD, PhD, Head of Translational Research, Institut Curie; and Keith Hoffmaster, PhD, Director, Global Program Management, Novartis. These speakers will share their strategic visions on how to tackle the next decades’ economic challenges in research and innovation.

    http://www.businesswire.com/news/home/20160119006350/en/%E2%80%9CFAID-2016%E2%80%9D-Symposium-Include-Presentations-Panel-Case

  5. 5
    Jan. 25, 2016 – “FAID 2016” symposium will include panel presentations on Rare Diseases: Models and Opportunities as part of its February 9-10, 2016, program

    In alphabetical order, FAID 2016 panelists on the topic of Rare Diseases: Models and Opportunities on February 10 will include: Yves Agid, MD, PhD, Founder & Scientific Advisor, ICM Brain & Spine Institute; Fanny Mochel, MD, PhD, Head, Metabolic Research Group, ICM; José-Alain Sahel, MD, Founder & Director, Institut de la Vision; and, Michel Vellard, PhD, VP Research, Ultragenyx Pharmaceuticals. These speakers will share their hands-on approaches to developing therapies in niche markets.  

    http://www.businesswire.com/news/home/20160125006344/en/%E2%80%9CFAID-2016%E2%80%9D-Symposium-Include-Panel-Presentations-Rare